WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Ownership - Who owns Gyre Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gyre Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas Wilson EastlingDirector2025-04-1615,000$6.93
$103.95kBuy
Weiguo YeChief Operating Officer2025-03-27150,000$0.75
$112.50kBuy
Weiguo YeChief Operating Officer2025-03-26200,000$0.75
$150.00kBuy
Weiguo YeChief Operating Officer2025-03-24300,000$0.75
$225.00kBuy
Songjiang MaPresident2025-03-21174$10.00
$1.74kSell
Songjiang MaPresident2025-03-202,000$10.09
$20.18kSell
Songjiang MaPresident2025-03-192,000$10.13
$20.26kSell
Songjiang MaPresident2025-03-18242$10.24
$2.48kSell
Songjiang MaPresident2025-03-172,000$12.09
$24.18kSell
Songjiang MaPresident2025-03-142,000$12.31
$24.62kSell

1 of 9

GYRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GYRE insiders and whales buy or sell their stock.

GYRE Shareholders

What type of owners hold Gyre Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gni Group Ltd75.07%70,272,408$672.51MInsider
Bvf Partners L P12.46%11,664,575$111.63MInsider
Nea Partners 10 L P8.36%7,827,024$74.90MInsider
Iii Eugene A. Trainor8.36%7,827,024$74.90MInsider
Investment 10 LLC6.59%6,171,669$59.06MInsider
C. Richard Kramlich4.88%4,572,845$43.76MInsider
Peter J. Barris4.88%4,570,845$43.74MInsider
M. James Barrett4.88%4,570,845$43.74MInsider
Scott D. Sandell4.88%4,569,845$43.73MInsider
Charles W. Newhall Iii4.88%4,567,512$43.71MInsider

1 of 3

GYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GYRE1.09%98.91%Net BuyingNet Buying
SYRE69.85%30.15%Net Selling
NTLA71.84%28.16%Net SellingNet Selling
ZYME52.10%47.90%Net BuyingNet Buying
RCUS59.71%40.29%Net BuyingNet Buying
View Top Biotech Stocks

Gyre Therapeutics Stock Ownership FAQ

Who owns Gyre Therapeutics?

Gyre Therapeutics (NASDAQ: GYRE) is owned by 1.91% institutional shareholders, 173.81% Gyre Therapeutics insiders, and 0.00% retail investors. Gni Group Ltd is the largest individual Gyre Therapeutics shareholder, owning 70.27M shares representing 75.07% of the company. Gni Group Ltd's Gyre Therapeutics shares are currently valued at $685.86M.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.